VFA
MRNS

Valeo Financial Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Valeo Financial Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-375
Closed -$4K – 2218
2020
Q2 		$4K Hold
375
– – ﹤0.01% 1635
2020
Q1 		$2K Hold
375
– – ﹤0.01% 1597
2019
Q4 		$3K Hold
375
– – ﹤0.01% 1426
2019
Q3 		$2K Hold
375
– – ﹤0.01% 1424
2019
Q2 		$6K Hold
375
– – ﹤0.01% 1177
2019
Q1 		$6K Buy
+375
New +$5.4K ﹤0.01% 1127

Other funds holding MRNS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Valeo Financial Advisors's MRNS Position: Q3 2020 in Review

Valeo Financial Advisors sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2020, closing a stake of 375 shares — an estimated $4K sold.

Valeo Financial Advisors first reported a position in MRNS in Q1 2019 and held it in 6 quarters. The position peaked at $6K in Q2 2019. 77 funds tracked by Wall St. Rank hold MRNS as of Q3 2020.

  • Valeo Financial Advisors reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 375 Marinus Pharmaceuticals, Inc shares in Q3 2020, an estimated $4K.
  • Valeo Financial Advisors first reported a position in Marinus Pharmaceuticals, Inc in Q1 2019 and held it in 6 quarters.
  • Valeo Financial Advisors's Marinus Pharmaceuticals, Inc position peaked at $6K in Q2 2019.
  • 77 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2020.

Based on Valeo Financial Advisors's 13F filing for Q3 2020, filed 28 Oct 2020.